- All sections
- C - Chemistrymetallurgy
- C40B - Combinatorial chemistrylibraries, e.g. chemical libraries
- C40B 30/02 - In silico screening
Patent holdings for IPC class C40B 30/02
Total number of patents in this class: 219
10-year publication summary
63
|
41
|
25
|
9
|
4
|
3
|
1
|
0
|
0
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Caris MPI, Inc. | 112 |
7 |
The Regents of the University of California | 20087 |
6 |
Zymeworks Inc. | 262 |
5 |
Massachusetts Institute of Technology | 10110 |
4 |
Psomagen, Inc. | 92 |
4 |
Fujitsu Limited | 18388 |
3 |
Council of Scientific & Industrial Research | 1439 |
3 |
Immatics Biotechnologies GmbH | 1153 |
3 |
University Health Network | 1051 |
3 |
Novartis AG | 10725 |
2 |
The Board of Trustees of the Leland Stanford Junior University | 6462 |
2 |
National Taiwan University | 1236 |
2 |
Ancestry.com DNA, LLC | 134 |
2 |
Biolauncher Ltd. | 3 |
2 |
City of Hope | 997 |
2 |
Dacadoo AG | 51 |
2 |
GeneNews Corporation | 2 |
2 |
GenePeeks, Inc. | 5 |
2 |
iNova Health System | 10 |
2 |
Institute of Biophysics, Chinese Academy of Sciences | 128 |
2 |
Other owners | 159 |